A Study of Atezolizumab in Combination With Cabozantinib Compared to Cabozantinib Alone in Participants With Advanced Renal Cell Carcinoma After Immune Checkpoint Inhibitor Treatment
Clinical trial NCT04338269 · TERMINATED
Trial details
- NCT number
- NCT04338269
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-28
- Primary completion
- 2023-01-03
- Enrollment
- 522
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.